New radioimmunotherapy approach eliminates cancer stem cells in preclinical models of ovarian cancer
A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard.